A genome-wide genetic screen identified targets for destabilizing the parasitophorous vacuole of Chlamydia trachomatis. In this study, we have employed the power of the just recently established molecular genetic toolbox for Chlamydia to develop the first tool able to specifically detect early forms of membrane damage in the parasitophorous vacuole of Chlamydia (the inclusion) and to localize individual Chlamydia entering the host cell cytosol. Critically, this advance enabled us to conduct a thorough mechanistic follow-up of results from a genome-wide CRISPR knockout screen, which uncovered that the pathogen employs the secreted effector CpoS, a modulator of membrane trafficking, to stabilize its vacuole by ensuring adequate sphingolipid supply. Notably, we observed that a simultaneous blockade of two lipid transport routes to the inclusion destabilized the vacuole early, leading to infection clearance without damaging the host cell. Thereby, this work can provide a foundation for a future therapeutic targeting of the Chlamydia inclusion. The project was primarily driven by Mohammed Rizwan Babu Sait and Lana Jachmann, two members of the Sixt lab, yet was a team effort with key contributions from several former lab members and project students, as well as our collaborators from the Karolinska Institut, the Freie Universität Berlin, and the microscopy facilities at Umeå University.
Karsten Meier - first PhD student from Sixt lab defended his thesis
28/05/2024
After a five year journey, Karsten Meier reached the finish line of his PhD marathon and sucessfully defended his thesis entitled “Identifying, characterizing, and targeting chlamydial virulence factors to unleash the power of host cell-autonomous immunity”. Congratulations Dr. Meier! We are so proud! But we will miss you so much in the lab!
Winter fun in Umeå
07/12/2023
The Sixt lab enjoying a nice after lunch walk in the snow.
New research article on bioRvix
30/11/2023
A multi-strategy antimicrobial discovery approach reveals new ways to combat Chlamydia. Here, we describe a multi-strategy screening campaign carried out to probe the chemical space for novel selective antichlamydial activities. Over sixty potent compounds dissimilar to known antibiotics were identified. These may now serve as starting points for developing more sustainable therapeutics and as tools for dissecting the unique biology of Chlamydia. The project was primarily driven by Magnus Ölander, a terrific postdoc in the Sixt lab, yet was also a team effort involving important contributions from several lab members, as well as from our collaborators in the lab of Björn Schröder.
The Chlamydia effector CpoS modulates the inclusion microenvironment and restricts the interferon response by acting on Rab GTPases. Finally out, the second “season” of our story of CpoS. In this study, we discovered the importance of Inc-Inc interactions in the establishment of inclusion membrane microdomains, as well as the role of CpoS-Rab35 interactions in the suppression of the host cellular defense by C. trachomatis. Congratulations, Karsten, to your first first-author paper. And many thanks to all co-authors – this was a great team effort!
Bringing genetics to heretofore intractable obligate intracellular bacterial pathogens: Chlamydia and beyond. In this invited Pearls article (educational mini-review), we have summarized current approaches of, remaining challenges for, and opportunities arising from molecular genetic manipulation of obligate intracellular bacteria, with a focus on Chlamydia spp.
One new postdoc project available. Generously funded by the Kempe Foundations! More information about the project and application can be found here.
New commentary in Cell Host & Microbe
13/04/2022
Keeping the home intact – lessons from Chlamydia. A commentary describing the path that lead to the birth of the Sixt Lab. Thank you, Cell Host & Microbe, for supporting this path and for highlighting our group and research in context of the 15-year anniversary edition of Cell Host & Microbe!
Another wonderful addition to the team! Gözde Türköz made the long trip from Turkey to join our battle against Chlamydia.
New preprint on bioRxiv
18/02/2022
The Chlamydia protein CpoS modulates the inclusion microenvironment and restricts the interferon response by acting on Rab35. Finally, available online on bioRxiv, the second “season” of our story of CpoS and first first-author paper of PhD student Karsten Meier!
And our lab is growing further. After successful completion of her master studies in Germany, Lana Jachmann joined our group in June 2021 to face new challenges.
Meet Milica, a new postdoc in our team!
03/06/2021
We happily announce that Milica Milivojevic joined our team in March 2021. To find out more about our new team member, please check out this interview with Milica in the MIMS spotlight series: Link to interview.
The SixtLab is hiring!
09/02/2021
Two new postdoc projects available. More information here.
Welcome Rizwan!
16/12/2020
We are so happy that Rizwan successfully defended his PhD thesis in Germany and now joined our lab in Umeå for postdoctoral studies on the mechanisms of defensive host cell death during infection with Chlamydia. Rizwan is already quite busy in the cell culture hood. Welcome in the team, Rizwan!
New publication from collaborative project in Scientific Reports
26/10/2020
Modelling of variables in
cellular infection reveals CXCL10 levels are regulated by human genetic
variation and the Chlamydia-encoded CPAF protease. In this project,
our collaborators from the Ko lab (Duke University (USA)) developed a smart
approach to unveil the role of the Chlamydia
protease CPAF in regulating chemokine levels. We congratulate the Ko lab and
look forward to future collaborations!
Host cell death during infection with Chlamydia: a double-edged sword. A comprehensive review that highlights recent advances and major knowledge gaps in our understanding of the diverse mechanisms and roles of pathogen-mediated host cell death modulation during infection with the obligate intracellular pathogen Chlamydia trachomatis and its relatives.
Nastia joined our team as project assistant to obtain deeper insights into Chlamydia inclusion stability. Welcome in the team, Nastia!
New publication from collaborative project in Science
21/08/2020
Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage. In
this project, our collaborators from the Zitvogel and Kroemer labs
(Institut Gustave Roussy, France) revealed how bacteriophages that
infect the natural intestinal microbiota can promote anti-cancer
immunity. We are thankful that we could contribute and congratulate the
teams of Laurence Zitvogel and Guido Kroemer to their exciting novel
insights!
Lucía joined our team for a summer project to assist Karsten in uncovering the mode of action of a Chlamydia virulence factor. It’s so nice to have you in the team, Lucía!
It is Pancake Thursday!
30/04/2020
Don't forget to move the trophies to the new office!
24/04/2020
We are moving into new lab rooms. Preparations ongoing...
22/04/2020
The Sixt Lab Website is online!
07/04/2020
We are so happy that our website is finally online. Welcome, visitor!